Figure 2. Incidence of new or increased-severity TEAEs for the most common early-onset TEAEs in participants in the narcolepsy study.

All events depicted represent new-onset TEAEs. Participants could list > 1 TEAE as reason for discontinuation (hence, the sum of those discontinuing due to individual TEAEs is greater than the overall discontinuations due to TEAEs). ^aPercentage of participants who discontinued due to AEs is based on the total number of participants who discontinued due to any common early-onset TEAE (n = 1). AE = adverse event, TEAE = treatment-emergent adverse event.